FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA New Product-Specific Guidances

FDA publishes 46 new or revised product-specific guidances to spur the development of generic drugs.

latest-news-card-1
FDA General

Appropriators Cut FDA Budget by $600 million

A House Appropriations Subcommittee cuts FDAs fiscal year 2024 budget request by $600 million (8.3%).

latest-news-card-1
Biologics

Panel Backs Pfizers RSV Vaccine

FDAs Vaccines and Related Biological Products Advisory Committee votes to recommend approval of a Pfizer BLA for its Abrysvo (RSVpreF) vaccine for pre...

latest-news-card-1
Human Drugs

2 Pediatric Drug Approval Guidances

FDA publishes two guidances to assist in the development of drugs, biologics, and vaccines for pediatric use.

latest-news-card-1
Human Drugs

Partial Hold Modified in Myotonic Dystrophy Study

FDA modifies a partial clinical hold on an Avidity Biosciences study involving AOC 1001, allowing Avidity to double the number of participants in the ...

latest-news-card-1
Human Drugs

ICU Medical Recalls Pumps Over Battery Defect

ICU Medical recalls the replacement batteries in its in Plum A+ & Plum A+3 Infusion Systems due to a manufacturing defect by a battery supplier.

latest-news-card-1
Federal Register

Susceptibility Test Interpretive Criteria Updated

Federal Register notice: FDA posts its annual compilation of notices of updates to the agencys antimicrobial test interpretive criteria Web page.

latest-news-card-1
Federal Register

Device Panel to Tackle Health Equity

Federal Register notice: CDRH plans a 9/6 Patient Engagement Advisory Committee meeting that will discuss and make recommendations on advancing health...

latest-news-card-1
Human Drugs

Reviewers Question Intercepts Liver Drug

FDA asks the Gastrointestinal Drugs Advisory Committee whether it recommends approval of Intercepts obeticholic acid to treat pre-cirrhotic liver fibr...

latest-news-card-1

Bill to Use Industry Penalties for Cancer Research

A bipartisan group of members of Congress introduce legislation to redirect penalties paid by drug, cosmetic, supplement, and medical device companies...